SiliCycle receives its cannabis processing license from Health Canada

QUEBEC CITY, Aug. 5, 2020 /CNW Telbec/ – Senior management of SiliCycle is pleased to have taken a new step towards the commercialization of purified extracts of various cannabinoids with the obtention of its cannabis processing license from Health Canada. The Quebec-based company can thus move forward to transform the biomass of hemp and cannabis into pure, high-quality extracts.

The authorization provided by Health Canada allows SiliCycle to start production -at its new plant – located in Quebec City, which was completed in early 2020. More than 22 million dollars were invested in construction and equipment acquisition costs related to carrying out the extraction, purification and packaging processes used by the company and its affiliate PurCann Pharma, which is dedicated to this field of expertise.

“There is certainly a craze for the production of cannabinoids, but the interest lies particularly in the ability to offer these substances in their pure form – This is precisely where we set ourselves apart with processes that allow us to produce  the desired quantities and proportions in a stable and reproducible manner despite the variations -in the biomass. This is how we will be able to provide customers with -reliable products, an essential condition for commercial success,” said SiliCycle President Hugo St-Laurent.

The new plant will process up to 100,000 kg of biomass per year, thus providing SiliCycle with the tools to produce thousands of kilograms of extracts – with varying degrees of purity according to the needs of its customers. The new plant is also equipped with units for the preparation of finished products including tinctures, sprays and so on, to meet customer needs.-

“We are applying all the expertise acquired in the pharmaceutical field to ensure product quality and reproducibility according to very high standards. Our scientific approach is therefore rigorous and proven, combined with the quality of our new facilities and the presence of high-caliber researchers within our team, thus we are well positioned to successfully market our products”, said Pierre Plante, Vice President – Operations for PurCann Pharma.

About SiliCycle Inc.
Founded in 1995, SiliCycle Inc. is a worldwide leader in the development, the manufacturing and the commercialization of high value silica-based and specialty products for chromatography, analytical and organic chemistry. Our business extends to more than fifty countries and our customer portfolio includes companies in the pharmaceutical and biopharmaceutical industries, contract research and manufacturing organizations as well as university laboratories, hospital research centers, agriculture and food, environmental, petrochemicals, and industrial process companies. Our offer includes among others services:

• Aqueous or organic extraction of various molecules from various biomasses
• Customized purification of the scale from laboratory to industrial
• Development of analytical methods to achieve the desired levels of purity
• Synthesis of molecules of interest
• Production of active ingredients such as omega-3s, polyphenols and CBD / THC molecules

About PurCann Pharma

PurCann Pharma is specialized in the manufacturing and commercialization of cannabinoid-rich extracts from hemp and cannabis grown in Canada. A significant portion of these biomasses is certified Organic. The purified and standardized extracts rich in CBD and / or THC are sold in bulk or as finished products, such as tinctures, sprays, softgels. PurCann Pharma also offers R&D, extraction, purification and packaging services.

Stay Connected:
To learn more about SiliCycle’s activities, follow us on social media:

SOURCE SiliCycle

For further information: Hugo St-Laurent, President, 418 874.0054, [email protected]; Pierre Plante, Vice President – Operations, PurCann Pharma, 514 804-4416, [email protected]; Pierre Drapeau, Head of Public Affairs, 418 456.6385, [email protected]

Related Links

https://www.silicycle.com/ca/